ClearPoint Neuro, Inc. (CLPT)
CLPT Stock Price Chart
Explore ClearPoint Neuro, Inc. interactive price chart. Choose custom timeframes to analyze CLPT price movements and trends.
CLPT Company Profile
Discover essential business fundamentals and corporate details for ClearPoint Neuro, Inc. (CLPT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
22 May 2012
Employees
115.00
Website
https://www.clearpointneuro.comCEO
Joseph Michael Burnett
Description
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.
CLPT Financial Timeline
Browse a chronological timeline of ClearPoint Neuro, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Aug 2026
EPS estimate is -$0.27, while revenue estimate is $12.73m.
Earnings released on 13 May 2026
EPS came in at -$0.32 falling short of the estimated -$0.28 by -14.29%, while revenue for the quarter reached $12.13m , beating expectations by +1.35%.
Earnings released on 17 Mar 2026
EPS came in at -$0.27 falling short of the estimated -$0.22 by -22.73%, while revenue for the quarter reached $10.40m , beating expectations by +3.48%.
Earnings released on 6 Nov 2025
EPS came in at -$0.21 falling short of the estimated -$0.20 by -5.00%, while revenue for the quarter reached $8.86m , missing expectations by -14.80%.
Earnings released on 12 Aug 2025
EPS came in at -$0.21 falling short of the estimated -$0.20 by -5.00%, while revenue for the quarter reached $9.22m , missing expectations by -5.97%.
Earnings released on 13 May 2025
EPS came in at -$0.22 falling short of the estimated -$0.15 by -46.67%, while revenue for the quarter reached $8.49m , missing expectations by -7.44%.
Earnings released on 26 Feb 2025
EPS came in at -$0.20 falling short of the estimated -$0.15 by -33.33%, while revenue for the quarter reached $7.77m , missing expectations by -5.57%.
Earnings released on 7 Nov 2024
EPS came in at -$0.18 falling short of the estimated -$0.17 by -5.88%, while revenue for the quarter reached $8.12m , beating expectations by +4.40%.
Earnings released on 7 Aug 2024
EPS came in at -$0.16 surpassing the estimated -$0.19 by +15.79%, while revenue for the quarter reached $7.86m , beating expectations by +7.20%.
Earnings released on 7 May 2024
EPS came in at -$0.16 surpassing the estimated -$0.19 by +15.79%, while revenue for the quarter reached $7.64m , beating expectations by +9.28%.
Earnings released on 12 Mar 2024
EPS came in at -$0.19 surpassing the estimated -$0.22 by +13.64%, while revenue for the quarter reached $6.81m , beating expectations by +4.29%.
Earnings released on 9 Nov 2023
EPS came in at -$0.20 surpassing the estimated -$0.25 by +20.00%, while revenue for the quarter reached $5.76m , missing expectations by -9.26%.
Earnings released on 8 Aug 2023
EPS came in at -$0.29 falling short of the estimated -$0.18 by -61.11%, while revenue for the quarter reached $5.95m , beating expectations by +0.85%.
Earnings released on 11 May 2023
EPS came in at -$0.23 falling short of the estimated -$0.18 by -27.78%, while revenue for the quarter reached $5.43m , beating expectations by +6.53%.
Earnings released on 1 Mar 2023
EPS came in at -$0.18 surpassing the estimated -$0.22 by +18.18%, while revenue for the quarter reached $5.17m , missing expectations by -0.50%.
Earnings released on 8 Nov 2022
EPS came in at -$0.15 surpassing the estimated -$0.19 by +21.05%, while revenue for the quarter reached $5.15m , missing expectations by -4.70%.
Earnings released on 9 Aug 2022
EPS came in at -$0.18 matching the estimated -$0.18, while revenue for the quarter reached $5.20m , beating expectations by +2.32%.
Earnings released on 11 May 2022
EPS came in at -$0.17 surpassing the estimated -$0.20 by +15.00%, while revenue for the quarter reached $5.03m , beating expectations by +20.27%.
Earnings released on 1 Mar 2022
EPS came in at -$0.19 matching the estimated -$0.19, while revenue for the quarter reached $4.28m , missing expectations by -0.42%.
Earnings released on 9 Nov 2021
EPS came in at -$0.18 falling short of the estimated -$0.16 by -12.50%, while revenue for the quarter reached $4.57m , beating expectations by +14.35%.
Earnings released on 10 Aug 2021
EPS came in at -$0.17 falling short of the estimated -$0.14 by -21.43%, while revenue for the quarter reached $3.41m , missing expectations by -7.26%.
CLPT Stock Performance
Access detailed CLPT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
